OOIR: Observatory of International Research

Papers

(The H4-Index of Arthritis Care & Research is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Lived and care experiences of chronic musculoskeletal shoulder pain in Australian adults: A qualitative study	111
Developing and Validating Methods to Assemble Systemic Lupus Erythematosus Births in the Electronic Health Record	81
Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: ASingle‐CenterProspective Study	78
Long‐Term Outcomes of Children Born to Anti‐Ro Antibody–Positive Mothers With and Without Rheumatic Disease	76
Systemic Lupus Erythematosus Symptom Clusters and Their Association With Patient‐Reported Outcomes and Treatment: Analysis of Real‐World Data	66
Using Data‐Driven Approaches to Classify and Predict Health Care Spending in Patients With Gout Using Urate‐Lowering Therapy	61
Needs Assessment of Musculoskeletal Ultrasound Training in North American Pediatric Rheumatology Fellowship Programs	61
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An ARChiVe Registry Cohort Study	57
Does Higher Quality of Care in Systemic Lupus Erythematosus Improve Quality of Life?	54
Pregnancy Outcomes from a Multidisciplinary Obstetric‐Medicine/Rheumatology Clinic in the United States: A Five‐Year Retrospective Analysis	53
Issue Information	45
Issue Information	44
ARP Announcements	41
Relationship Between Changing Body Mass Index and Serum Uric Acid Alteration Among Clinically Apparently Healthy Korean Men	40
Physician Views and Attitudes Regarding Tobacco‐Cessation Strategies for Patients with Rheumatoid Arthritis	39
Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double‐Blind, Placebo‐Controlled Trial	38
Opioid Use Among Medicare Beneficiaries With Knee Osteoarthritis: Prevalence and Correlates of Chronic Use	37
Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody–Associated Vasculitis	37
Imaging Features of Calcium Pyrophosphate Deposition Disease: Consensus Definitions From an International Multidisciplinary Working Group	36
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases	35
Cost‐effectiveness of low dose colchicine prophylaxis when starting allopurinol using the “start‐low go‐slow” approach for gout: evidence from a non‐inferiority randomised double‐blind placebo‐control	34
Virtually Speaking: The Impact of a Nationwide Synchronous and Asynchronous Learning Forum	34
Adipokines and Associations with Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis	34
Serum CCL24 as a Biomarker of Fibrotic and Vascular Disease Severity in Systemic Sclerosis	33
Association of Changes in Hand Pain With BMI, Employment, and Mental Well‐Being Over Four Years in Patients With Hand Osteoarthritis	33

Treatment of Sarcoidosis in US Rheumatology Practices: Data From the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) Registry	33
Baseline Dual‐Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate‐Lowering Therapy	33
Development of the American College of Rheumatology Patient‐Reported Outcome Quality Measures for Systemic Lupus Erythematosus	32
Clinically Relevant Subgroups Among Athletes Who Have Ruptured Their Anterior Cruciate Ligaments: A Delaware‐Oslo Cohort Study	32
Associations Between Baseline and Longitudinal Semiautomated Quantitative Joint Space Width at the Hip and Incident Hip Osteoarthritis: Data From a Community‐Based Cohort	32
Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide	31